started · updated
Retatrutide counterfeit drugs flood black markets
Counterfeit versions of the experimental weight-loss drug retatrutide are flooding the black market, creating significant challenges for Eli Lilly and global regulators. Although the drug is still undergoing clinical trials and has not yet received approval for human use from any regulatory body, illicit vials are being widely distributed.
In the UK, these counterfeit products are reportedly being sold through various channels, including gyms, beauty salons, hairdressers, social media, and street vendors. Experts have noted that this is a rare instance where copycat versions of an experimental drug in the testing phase have become so widely available. Health professionals have expressed concern that individuals are injecting unregulated, illegal substances under the impression that they are safe.
Entities
Eli Lilly · FDA · Retatrutide